Genetics of macrovascular complications in type 2 diabetes

doi:10.4239/wjd.v12.i8.1200

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4428)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

350

WORD

161

HTML

2395

Figures (1-1)

278

Tables (1-2)

149

Sum=3333

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

365

Download

730

Sum=1095

Aug 15, 2021 (publication date) through Apr 16, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Aug 15, 2021; 12(8): 1200-1219
Published online Aug 15, 2021. doi: 10.4239/wjd.v12.i8.1200

Full Size Figure Download Figure

Figure 1 Genetic and epigenetic factors involved in development of diabetic complications. AGE: Advanced glycation end-products formation; ROS: Reactive oxygen species.

Citation: Tonyan ZN, Nasykhova YA, Danilova MM, Glotov AS. Genetics of macrovascular complications in type 2 diabetes. World J Diabetes 2021; 12(8): 1200-1219
URL: https://www.wjgnet.com/1948-9358/full/v12/i8/1200.htm
DOI: https://dx.doi.org/10.4239/wjd.v12.i8.1200